Report
Dave Nicoski ...
  • Ross LaDuke
EUR 85.33 For Business Accounts Only

Int'l Macro Vision: Sector Synopsis

Int'l Equity Strategy


Market indicators continue to lean bearish amid the ongoing Russia-Ukraine conflict, rapidly rising global rates/inflation, and tightening monetary policy. Moreover, the broad global indexes remain below our key “lines in the sand,” including $54 on MSCI ACWI ex-US (ACWX-US), $75.25 on MSCI EAFE (EFA-US), and the 200-day MA/$99 on MSCI ACWI (ACWI-US). As long as prices are below the aforementioned levels, we are bearish at the index level, and we expect more volatility and lower prices ahead. From a Sector perspective, we want to remain overweight commodity Sectors (Energy and Materials) and also defensives (Health Care, Utilities, and Consumer Staples). There are also bright spots within Financials (esp. insurance names), Manufacturing, Transportation, and Telecomm, but it is hard to paint them with a broad brush.



Below we summarize the basis for our bearish outlook.



Bearish-Leaning Indicators:

In addition to the aforementioned MSCI indexes being below our “lines in the sand,” MSCI EM (EEM-US) and China (MCHI-US, KWEB-US) remain in 14-month downtrends.
Japan's TOPIX and Nikkei 225, and Hong Kong's Hang Seng each remain in downtrends. Europe's EURO STOXX 50 remains below resistance in the 4040-4090 range. Germany's DAX remains below major resistance in the 14,815-14,950 zone.
The US dollar remains in an uptrend and above support at 97-97.70.
MSCI ACWI defensive Sectors including Consumer Staples, Utilities, Health Care, and Real Estate are hitting 1-2-year relative strength highs (vs. MSCI ACWI).


Bottom Line: Broad global MSCI equity indexes remain bearish, as do indexes in Japan, Hong Kong, China, Europe, and Germany. Until we see indexes break above the aforementioned levels, we cannot be bullish. In terms of Sector allocations, remain overweight Energy and Materials with the secular commodity bull market intact. Defensive Sectors are also hitting 1-2-year RS highs, and we recommend overweights to Health Care, Utilities, and Consumer Staples.
Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch